Post-Op Incentive Spirometry Not Beneficial After Bariatric Surgery

Share this content:
Post-Op Incentive Spirometry Not Beneficial After Bariatric Surgery
Post-Op Incentive Spirometry Not Beneficial After Bariatric Surgery

WEDNESDAY, Jan. 11, 2017 (HealthDay News) -- For patients undergoing bariatric surgery, postoperative incentive spirometry (IS) does not affect postoperative hypoxemia, arterial oxygen saturation, or postoperative pulmonary complications, according to a study published online Jan. 11 in JAMA Surgery.

Haddon Pantel, M.D., from the Lahey Hospital and Medical Center in Burlington, Mass., and colleagues conducted a randomized noninferiority trial involving 224 patients undergoing bariatric surgery. Patients were randomized to postoperative IS (control group; IS used 10 times every hour while awake) or clinical observation (test group).

The researchers observed no significant between-group differences in the frequency of postoperative hypoxemia at six, 12, or 24 postoperative hours (11.9 versus 10.4 percent [P= 0.72]; 5.4 versus 8.2 percent [P = 0.40], and 3.7 versus 4.6 percent [P = 0.73], respectively). The mean arterial oxygen saturation level did not differ significantly between the control and test groups at six, 12, or 24 postoperative hours (94.9 versus 94.9 percent [P = 0.99]; 95.4 versus 95.1 percent [P = 0.40]; and 95.7 versus 95.6 percent [P = 0.69], respectively). There was no significant difference observed between the groups in 30-day postoperative pulmonary complications (7.1 versus 3.6 percent [P = 0.24]).

"Based on these findings, the routine use of IS is not recommended after bariatric surgery in its current implementation," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »